Rudi Jansen

Rudi Jansen has over 40 years of experience in the pharmaceutical industry. Rudi is currently the Chief Business Officer and Chairman of the non-Executive Board at Pleco Therapeutics BV, where they are involved in the development of cancer therapies. Prior to this, they worked as the Director of Business Development at Obvius Pharmaceuticals B.V from 2014 to 2020. Rudi also held positions at IDIS Pharmaceuticals, where they served as the Director of Commercial Development and the Director of International Sales. Additionally, they worked as an Advisor to the Board at Care4Pharma and founded and managed Jansen Pharma sprl, a management and consulting company specializing in the pharmaceutical industry. Rudi has also held various leadership roles at companies such as Strides Arcolab Limited, Intsel-Chimos, Wockhardt Ltd., The Upjohn Company, and Upjohn.

Rudi Jansen attended Alexander Hegius College from 1971 to 1983. Following that, they continued their education at Leiden University, focusing on the field of Infectious Diseases. No degree information is available for this period.